HCPCS J2281
Injection moxifloxacin (fres kabi)
Last reviewed August 2026 · DataLily AI data team
Pilot Analysis
Get the complete HCPCS J2281 analysis
Tell us where to send it. Our team will prepare an analysis of HCPCS J2281 covering what payers reimburse across markets and where your rate may sit, and email it to you within 5-10 business days. Need it faster? Book a demo.
HCPCS J2281 at a glance
- Code
- J2281
- Code type
- CPT/HCPCS
- Short descriptor
- Inj moxifloxacin (fres kabi)
- Category
- ASC Ancillary
- ASC eligibility
- ASC-eligible (ancillary)
- Typical setting
- Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
What is HCPCS code J2281?
HCPCS J2281 is a CPT/HCPCS procedure code for injection moxifloxacin (fres kabi). Its official short descriptor is "Inj moxifloxacin (fres kabi)". In the ASC context it is grouped under ASC Ancillary.
Is HCPCS J2281 eligible in an ambulatory surgery center (ASC)?
HCPCS J2281 is an ancillary service that can be provided in the ASC setting when it supports a surgical procedure.
Where is HCPCS J2281 typically performed?
Ambulatory surgery center (POS 24) or hospital outpatient department (POS 22).
Reference information about ASC eligibility and typical procedure setting. Codes, descriptors, and ASC-eligibility status change over time. This is a coding reference, not billing, coding, or legal advice. Always verify against current guidance and individual payer policy before scheduling or billing. CPT is a registered trademark of the American Medical Association. Read the DataLily AI data methodology.